Sensitization of <scp>glutamate receptor</scp>‐mediated pain behaviour via nerve growth factor‐dependent phosphorylation of transient receptor potential V1 under inflammatory conditions

  • Takayoshi Masuoka
    Department of Pharmacology, School of Medicine Kanazawa Medical University Uchinada Ishikawa Japan
  • Yuka Yamashita
    Department of Pharmacology, School of Medicine Kanazawa Medical University Uchinada Ishikawa Japan
  • Junko Yoshida
    Department of Pharmacology, School of Medicine Kanazawa Medical University Uchinada Ishikawa Japan
  • Katsuya Nakano
    Department of Pharmacology, School of Medicine Kanazawa Medical University Uchinada Ishikawa Japan
  • Masashi Tawa
    Department of Pharmacology, School of Medicine Kanazawa Medical University Uchinada Ishikawa Japan
  • Matomo Nishio
    Department of Pharmacology, School of Medicine Kanazawa Medical University Uchinada Ishikawa Japan
  • Takaharu Ishibashi
    Department of Pharmacology, School of Medicine Kanazawa Medical University Uchinada Ishikawa Japan

抄録

<jats:sec><jats:title>Background and Purpose</jats:title><jats:p>Glutamate and metabotropic glutamate (mGlu) receptors on primary sensory neurons are crucial in modulating pain sensitivity. However, it is unclear how inflammation affects mGlu receptor‐mediated nociceptive responses. We therefore investigated the effects of mGlu<jats:sub>1/5</jats:sub> receptor agonists on pain‐related behaviour during persistent inflammation and their underlying mechanisms.</jats:p></jats:sec><jats:sec><jats:title>Experimental Approach</jats:title><jats:p>Effects of a mGlu<jats:sub>1/5</jats:sub> receptor agonist on pain‐related behaviour during inflammation was assessed in mice. Intracellular calcium responses, membrane current responses, and protein expression in primary sensory neurons were examined using cultured dorsal root ganglion (DRG) neurons, dissociated from wild‐type and gene knockout mice.</jats:p></jats:sec><jats:sec><jats:title>Key Results</jats:title><jats:p>Persistent inflammation induced by complete Freund's adjuvant increased the duration of mGlu<jats:sub>1/5</jats:sub> receptor‐mediated pain behaviour, which was antagonized by inhibition of nerve growth factor (NGF)–tropomyosin receptor kinase A (TrkA) signalling. Calcium imaging revealed that NGF treatment increased the number of cultured DRG neurons responding to mGlu<jats:sub>1/5</jats:sub> receptor activation. Stimulation of mGlu<jats:sub>1/5</jats:sub> receptors in NGF‐treated DRG neurons induced inward currents through TRPV1 channels in association with PLC but not with IP<jats:sub>3</jats:sub> receptors. NGF treatment also increased the number of neurons responding to a DAG analogue via TRPV1 channel activation. Furthermore, NGF up‐regulated expression of TRPV1 and A‐kinase anchoring protein 5 (AKAP5), resulting in increased AKAP5‐dependent TRPV1 phosphorylation. AKAP5 knockout mice did not exhibit mGlu<jats:sub>1/5</jats:sub> receptor‐mediated excitation in NGF‐treated DRG neurons or pain response facilitation under inflammatory conditions.</jats:p></jats:sec><jats:sec><jats:title>Conclusions and Implications</jats:title><jats:p>NGF augments glutamate‐ and mGlu<jats:sub>1/5</jats:sub> receptor‐mediated excitation of nociceptive neurons by AKAP5‐dependent phosphorylation of TRPV1 channels, potentiating hypersensitivity to glutamate in inflamed tissues.</jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (50)*注記

もっと見る

関連プロジェクト

もっと見る

問題の指摘

ページトップへ